» Articles » PMID: 15456495

Evaluation of the Role of Platelet Integrins in Fibronectin-dependent Spreading and Adhesion

Overview
Publisher Elsevier
Specialty Hematology
Date 2004 Oct 1
PMID 15456495
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have shown that platelet adhesion and subsequent aggregation can occur in vivo in the absence of the two principal platelets adhesive ligands, von Willebrand factor and fibrinogen. These results highlight a possible role for fibronectin in supporting thrombus formation.

Objective And Methods: To evaluate the platelet integrins and subsequent activation pathways associated with fibronectin-dependent platelet adhesion utilizing both human and murine platelets.

Results: Platelets can adhere to fibronectin via the integrin alpha(IIb)beta(3), leading to formation of lamellipodia. This is mediated through an interaction with the tenth type III domain in fibronectin. Spreading on fibronectin promotes alpha(IIb)beta(3)-mediated Ca(2+) mobilization and tyrosine phosphorylation of focal adhesion kinase and phospholipase C gamma2. In contrast, studies with blocking antibodies and mice demonstrate that alpha(5)beta(1) and alpha(v)beta(3) support adhesion and promote formation of filopodia but not lamellipodia or tyrosine phosphorylation of these proteins. Further, neither alpha(5)beta(1) nor alpha(v)beta(3) is able to induce formation of lamellipodia in the presence of platelets agonists, such as collagen-related-peptide (CRP).

Conclusions: These observations demonstrate that integrins alpha(5)beta(1) and alpha(v)beta(3) support platelet adhesion and the generation of filopodia but that, in contrast to the integrin alpha(IIb)beta(3), are unable to promote formation of lamellipodia.

Citing Articles

Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.

Mengyuan H, Aixue L, Yongwei G, Qingqing C, Huanhuan C, Xiaoyan L J Nanobiotechnology. 2024; 22(1):604.

PMID: 39370518 PMC: 11456251. DOI: 10.1186/s12951-024-02835-4.


Thrombogenicity of biodegradable metals.

Anderson D, Le H, Vu H, Johnson J, Aslan J, Goldman J Bioact Mater. 2024; 38:411-421.

PMID: 38774458 PMC: 11107095. DOI: 10.1016/j.bioactmat.2024.05.002.


Development potential of extracellular matrix hydrogels as hemostatic materials.

Cai D, Weng W Front Bioeng Biotechnol. 2023; 11:1187474.

PMID: 37383519 PMC: 10294235. DOI: 10.3389/fbioe.2023.1187474.


Matrix stiffness controls megakaryocyte adhesion, fibronectin fibrillogenesis, and proplatelet formation through Itgβ3.

Guinard I, Nguyen T, Brassard-Jollive N, Weber J, Ruch L, Reininger L Blood Adv. 2023; 7(15):4003-4018.

PMID: 37171626 PMC: 10410137. DOI: 10.1182/bloodadvances.2022008680.


Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.

Zheng T, Parra-Izquierdo I, Reitsma S, Heinrich M, Larson M, Shatzel J Am J Physiol Cell Physiol. 2022; 323(4):C1231-C1250.

PMID: 35938677 PMC: 9576167. DOI: 10.1152/ajpcell.00040.2022.